Sunny S. Po
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sunny S. Po has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
Benjamin J. Scherlag
Department of Medicine and Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
16 shared publicationsRalph Lazzara
Department of Medicine and Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
12 shared publicationsWarren M. Jackman
Heart Rhythm Institute, University of Oklahoma Health Sciences Center (S.S., W.M.J., D.L., H.N., K.B., K.E., S.S.P.).
10 shared publicationsStavros Stavrakis
Section of Cardiovascular Diseases and Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
9 shared publications- Benjamin J. Scherlag
University of Oklahoma Health Sciences Center
8 shared publications Lilei Yu
Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, No. 9 ZhangZhiDong Street, Wuchang District, Wuhan, Hubei, China
8 shared publications
Latest Publications
- Open Access
Autonomics, More Than Fibrosis, Predict Postoperative Atrial Fibrillation
Background: Postoperative atrial fibrillation (POAF) is a common complication of cardiac surgery with POAF susceptibility thought to be primarily the result of pre-existing structural atrial disease, specifically fibrosis. We tested this hypothesis directly by combining preoperative imaging of atrial fibrosis with continuous physiological monitoring before POAF onset. Methods: This prospective single center study (2023–2025) comprised 6,697 adults without prior atrial fibrillation (AF) undergoing elective cardiac surgery. Subjects were enrolled into three prespecified, non-overlapping cohorts: a mechanistic imaging cohort (n=52) to test whether preoperative atrial fibroblast activation predicts POAF; a physiological monitoring cohort (n=3,183) to characterize peri-event autonomic dynamics via time-resolved HRV analysis; and an independent prospective observability cohort (n=3,451) for validation. The prespecified primary analyses assessed time-domain and frequency-domain HRV across six consecutive 10- minute intervals during the 60 minutes preceding POAF onset. Generalized estimating equations models were applied. Results: Preoperative atrial fibroblast activation did not differ significantly between patients with (n=22) or without POAF (n=52). By contrast, in a physiological monitoring cohort (n=3,183), time-resolved heart rate variability analysis revealed progressive autonomic destabilization beginning approximately 20 minutes before POAF onset, with significant divergence in heart-rate-corrected SDNN in the final 10-minute pre-event interval (marginal mean difference 0.0139, 95% CI 0.0113–0.0164; P<0.001; Cohen’s d=0.728). This signal was independently validated in a prospective observability cohort (n=3,451), achieving fragment-level sensitivity of 69.6% and specificity of 97.5% at the 10-minute horizon. Conclusions: POAF is more closely associated with immediately preceding detectable autonomic destabilization than with preoperative structural substrate. These findings challenge the hypothesis that POAF susceptibility is structurally determined(structural-determinism) and reframe this frequent complication as a dynamic, state-dependent process that may be a target for active prevention.
Open AccessAutonomics, More Than Fibrosis, Predict Postoperative Atrial Fibrillation
Background: Postoperative atrial fibrillation (POAF) is a common complication of cardiac surgery with POAF susceptibility thought to be primarily the result of pre-existing structural atrial disease, specifically fibrosis. We tested this hypothesis directly by combining preoperative imaging of atrial fibrosis with continuous physiological monitoring before POAF onset. Methods: This prospective single center study (2023–2025) comprised 6,697 adults without prior atrial fibrillation (AF) undergoing elective cardiac surgery. Subjects were enrolled into three prespecified, non-overlapping cohorts: a mechanistic imaging cohort (n=52) to test whether preoperative atrial fibroblast activation predicts POAF; a physiological monitoring cohort (n=3,183) to characterize peri-event autonomic dynamics via time-resolved HRV analysis; and an independent prospective observability cohort (n=3,451) for validation. The prespecified primary analyses assessed time-domain and frequency-domain HRV across six consecutive 10- minute intervals during the 60 minutes preceding POAF onset. Generalized estimating equations models were applied. Results: Preoperative atrial fibroblast activation did not differ significantly between patients with (n=22) or without POAF (n=52). By contrast, in a physiological monitoring cohort (n=3,183), time-resolved heart rate variability analysis revealed progressive autonomic destabilization beginning approximately 20 minutes before POAF onset, with significant divergence in heart-rate-corrected SDNN in the final 10-minute pre-event interval (marginal mean difference 0.0139, 95% CI 0.0113–0.0164; P<0.001; Cohen’s d=0.728). This signal was independently validated in a prospective observability cohort (n=3,451), achieving fragment-level sensitivity of 69.6% and specificity of 97.5% at the 10-minute horizon. Conclusions: POAF is more closely associated with immediately preceding detectable autonomic destabilization than with preoperative structural substrate. These findings challenge the hypothesis that POAF susceptibility is structurally determined(structural-determinism) and reframe this frequent complication as a dynamic, state-dependent process that may be a target for active prevention.
- Open Access
- 15 May 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (6)
Alcohol consumption and risk of atrial fibrillation: a pairwise and network meta-analysis
Aims: Despite well-established evidence linking alcohol consumption to an increased risk of atrial fibrillation (AF), a clear threshold for safe intake remains undefined. Most clinical guidelines recommend abstinence or moderation, but lack specificity regarding quantitative limits and evidence-based thresholds for primary prevention of AF. Methods and results: We performed this systematic review, pairwise meta-analysis, and network meta-analysis to assess the association and dose–response relationship between varying quantities of alcohol consumption and incident AF. The predefined alcohol intake categories included: no intake, very low (60 g/day). The pairwise meta-analyses compared each intake category to no intake, and a frequentist network meta-analysis was conducted to integrate direct and indirect comparisons. Pooled risk ratio (RR) for AF incidence were estimated using random-effects models, and a subgroup analysis by sex was performed. Twenty-six studies with nearly 15 million participants were included. As compared to those with no alcohol intake, very high alcohol intake was associated with a 75% increased risk of incident AF (RR 1.75; 95% CI: 1.25–2.44, P = 0.04), intake below 48 g/day was associated with modestly lower AF risk, and the lowest risk was observed at <12 g/day (RR 0.72; 95% CI: 0.63–0.83). The weighted mean follow-up was approximately 6.4 years. Network meta-analysis confirmed these findings and demonstrated a significantly increased AF risk with very high compared to low (RR 1.91), moderate (RR 2.03), and high (RR 2.00) levels. Sex-stratified analyses showed similar results. Conclusion: Alcohol consumption is associated with a nonlinear, threshold-dependent relationship with incident AF. While low to moderate intake may not increase AF risk, intake beyond 60 g/day significantly increases the AF risk. These findings may suggest that a more liberal approach to alcohol consumption, particularly at low to moderate levels, could be reasonable in the general population, though further prospective studies are needed to confirm causality and refine individual risk stratification.
- 15 May 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (6)
Open AccessAlcohol consumption and risk of atrial fibrillation: a pairwise and network meta-analysis
Aims: Despite well-established evidence linking alcohol consumption to an increased risk of atrial fibrillation (AF), a clear threshold for safe intake remains undefined. Most clinical guidelines recommend abstinence or moderation, but lack specificity regarding quantitative limits and evidence-based thresholds for primary prevention of AF. Methods and results: We performed this systematic review, pairwise meta-analysis, and network meta-analysis to assess the association and dose–response relationship between varying quantities of alcohol consumption and incident AF. The predefined alcohol intake categories included: no intake, very low (60 g/day). The pairwise meta-analyses compared each intake category to no intake, and a frequentist network meta-analysis was conducted to integrate direct and indirect comparisons. Pooled risk ratio (RR) for AF incidence were estimated using random-effects models, and a subgroup analysis by sex was performed. Twenty-six studies with nearly 15 million participants were included. As compared to those with no alcohol intake, very high alcohol intake was associated with a 75% increased risk of incident AF (RR 1.75; 95% CI: 1.25–2.44, P = 0.04), intake below 48 g/day was associated with modestly lower AF risk, and the lowest risk was observed at <12 g/day (RR 0.72; 95% CI: 0.63–0.83). The weighted mean follow-up was approximately 6.4 years. Network meta-analysis confirmed these findings and demonstrated a significantly increased AF risk with very high compared to low (RR 1.91), moderate (RR 2.03), and high (RR 2.00) levels. Sex-stratified analyses showed similar results. Conclusion: Alcohol consumption is associated with a nonlinear, threshold-dependent relationship with incident AF. While low to moderate intake may not increase AF risk, intake beyond 60 g/day significantly increases the AF risk. These findings may suggest that a more liberal approach to alcohol consumption, particularly at low to moderate levels, could be reasonable in the general population, though further prospective studies are needed to confirm causality and refine individual risk stratification.
- 24 December 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (4) , 716-727
His-LBB Twig
- 24 December 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (4) , 716-727
His-LBB Twig
- Open Access
- 13 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (5) , oeaf098
Association between non-invasive auricular stimulation and blood pressure lowering: a systematic review and meta-analysis
Earlier clinical trials have investigated the efficacy of auricular stimulation for hypertension, but the overall evidence regarding the effect of non-invasive auricular stimulation on blood pressure (BP) reduction remains unclear. This systematic review summarizes the effects of non-invasive auricular stimulation on cardiovascular haemodynamics. We searched for studies published in English through PubMed, ICHUSHI, and Cochrane Central Library databases and reviewed randomized controlled trials involving adults. Data collection and analysis were performed on the relationships of non-invasive auricular electrical stimulation and acupressure with changes in haemodynamics. A meta-analysis was conducted on the effects of non-invasive auricular stimulation on systolic BP (SBP), diastolic BP (DBP), and heart rate (HR). In the primary analysis, effect sizes were extracted from 18 studies for a total analytic sample of n = 959. Non-invasive auricular stimulation significantly reduced in SBP [weighted mean difference (WMD) = −4.435 mmHg, 95% confidence interval (CI) (−7.037 to −1.832)], DBP [WMD = −2.212 mmHg, 95% CI (−3.734 to −0.690)], and HR [WMD = −3.069 beats/min, 95% CI (−5.389 to −0.749)]. Overall, heterogeneity in each analysis was high, which could be explained by the stimulation duration and baseline values of SBP, DBP, and HR. There were no serious adverse events across all 18 studies. Enhancing vagus nerve activity through non-invasive auricular stimulation leads to clinically safe reductions in BP and HR. Further studies are needed to clarify whether non-invasive auricular stimulation can be used as a viable treatment for hypertension.
- 13 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (5) , oeaf098
Open AccessAssociation between non-invasive auricular stimulation and blood pressure lowering: a systematic review and meta-analysis
Earlier clinical trials have investigated the efficacy of auricular stimulation for hypertension, but the overall evidence regarding the effect of non-invasive auricular stimulation on blood pressure (BP) reduction remains unclear. This systematic review summarizes the effects of non-invasive auricular stimulation on cardiovascular haemodynamics. We searched for studies published in English through PubMed, ICHUSHI, and Cochrane Central Library databases and reviewed randomized controlled trials involving adults. Data collection and analysis were performed on the relationships of non-invasive auricular electrical stimulation and acupressure with changes in haemodynamics. A meta-analysis was conducted on the effects of non-invasive auricular stimulation on systolic BP (SBP), diastolic BP (DBP), and heart rate (HR). In the primary analysis, effect sizes were extracted from 18 studies for a total analytic sample of n = 959. Non-invasive auricular stimulation significantly reduced in SBP [weighted mean difference (WMD) = −4.435 mmHg, 95% confidence interval (CI) (−7.037 to −1.832)], DBP [WMD = −2.212 mmHg, 95% CI (−3.734 to −0.690)], and HR [WMD = −3.069 beats/min, 95% CI (−5.389 to −0.749)]. Overall, heterogeneity in each analysis was high, which could be explained by the stimulation duration and baseline values of SBP, DBP, and HR. There were no serious adverse events across all 18 studies. Enhancing vagus nerve activity through non-invasive auricular stimulation leads to clinically safe reductions in BP and HR. Further studies are needed to clarify whether non-invasive auricular stimulation can be used as a viable treatment for hypertension.
- 25 June 2025
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 18 (10) , 1131-1144
From Paroxysmal to Persistent Atrial Fibrillation
- 25 June 2025
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 18 (10) , 1131-1144
From Paroxysmal to Persistent Atrial Fibrillation
- 22 January 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (4) , 776-788
Cardiovascular Disease-Specific Responses to Autonomic Denervation
- 22 January 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (4) , 776-788
Cardiovascular Disease-Specific Responses to Autonomic Denervation
- 15 March 2024
- Published by Elsevier in Heart Rhythm
- Vol. 21 (7) , 1184
Reply to the Editor— Cardioneuroablation: Excessive risk or excessive fear?
- 15 March 2024
- Published by Elsevier in Heart Rhythm
- Vol. 21 (7) , 1184
Reply to the Editor— Cardioneuroablation: Excessive risk or excessive fear?
- Open Access
- 6 February 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (3) , e032100
Robust Artificial Intelligence Tool for Atrial Fibrillation Diagnosis: Novel Development Approach Incorporating Both Atrial Electrograms and Surface ECG and Evaluation by Head‐to‐Head Comparison With Hospital‐Based Physician ECG Readers
Background: Atrial fibrillation (AF) increases risk of embolic stroke, and in postoperative patients, increases cost of care. Consequently, ECG screening for AF in high‐risk patients is important but labor‐intensive. Artificial intelligence (AI) may reduce AF detection workload, but AI development presents challenges. Methods and Results: We used a novel approach to AI development for AF detection using both surface ECG recordings and atrial epicardial electrograms obtained in postoperative cardiac patients. Atrial electrograms were used only to facilitate establishing true AF for AI development; this permitted the establishment of an AI‐based tool for subsequent AF detection using ECG records alone. A total of 5 million 30‐second epochs from 329 patients were annotated as AF or non‐AF by expert ECG readers for AI training and validation, while 5 million 30‐second epochs from 330 different patients were used for AI testing. AI performance was assessed at the epoch level as well as AF burden at the patient level. AI achieved an area under the receiver operating characteristic curve of 0.932 on validation and 0.953 on testing. At the epoch level, testing results showed means of AF detection sensitivity, specificity, negative predictive value, positive predictive value, and F1 (harmonic mean of positive predictive value and sensitivity) as 0.970, 0.814, 0.976, 0.776, and 0.862, respectively, while the intraclass correlation coefficient for AF burden detection was 0.952. At the patient level, AF burden sensitivity and positive predictivity were 96.2% and 94.5%, respectively. Conclusions: Use of both atrial electrograms and surface ECG permitted development of a robust AI‐based approach to postoperative AF recognition and AF burden assessment. This novel tool may enhance detection and management of AF, particularly in patients following operative cardiac surgery.
- 6 February 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (3) , e032100
Open AccessRobust Artificial Intelligence Tool for Atrial Fibrillation Diagnosis: Novel Development Approach Incorporating Both Atrial Electrograms and Surface ECG and Evaluation by Head‐to‐Head Comparison With Hospital‐Based Physician ECG Readers
Background: Atrial fibrillation (AF) increases risk of embolic stroke, and in postoperative patients, increases cost of care. Consequently, ECG screening for AF in high‐risk patients is important but labor‐intensive. Artificial intelligence (AI) may reduce AF detection workload, but AI development presents challenges. Methods and Results: We used a novel approach to AI development for AF detection using both surface ECG recordings and atrial epicardial electrograms obtained in postoperative cardiac patients. Atrial electrograms were used only to facilitate establishing true AF for AI development; this permitted the establishment of an AI‐based tool for subsequent AF detection using ECG records alone. A total of 5 million 30‐second epochs from 329 patients were annotated as AF or non‐AF by expert ECG readers for AI training and validation, while 5 million 30‐second epochs from 330 different patients were used for AI testing. AI performance was assessed at the epoch level as well as AF burden at the patient level. AI achieved an area under the receiver operating characteristic curve of 0.932 on validation and 0.953 on testing. At the epoch level, testing results showed means of AF detection sensitivity, specificity, negative predictive value, positive predictive value, and F1 (harmonic mean of positive predictive value and sensitivity) as 0.970, 0.814, 0.976, 0.776, and 0.862, respectively, while the intraclass correlation coefficient for AF burden detection was 0.952. At the patient level, AF burden sensitivity and positive predictivity were 96.2% and 94.5%, respectively. Conclusions: Use of both atrial electrograms and surface ECG permitted development of a robust AI‐based approach to postoperative AF recognition and AF burden assessment. This novel tool may enhance detection and management of AF, particularly in patients following operative cardiac surgery.
- 15 December 2023
- Published by Elsevier in Heart Rhythm
- Vol. 21 (4) , 464-470
Potential consequences of cardioneuroablation for vasovagal syncope: A call for appropriately designed, sham-controlled clinical trials
- 15 December 2023
- Published by Elsevier in Heart Rhythm
- Vol. 21 (4) , 464-470
Potential consequences of cardioneuroablation for vasovagal syncope: A call for appropriately designed, sham-controlled clinical trials
- Open Access
- 23 October 2023
- Published by Springer Nature in Trials
- Vol. 24 (1) , 1-10
Transcutaneous electrical vagus nerve stimulation to suppress premature ventricular complexes (TREAT PVC): study protocol for a multi-center, double-blind, randomized controlled trial
Background: The autonomic nervous system can be responsible for the initiation and maintenance of arrhythmias. Low-level tragus stimulation (LLTS), a noninvasive form of autonomic neuromodulation, has been shown to be effective in treating atrial fibrillation. We intended to treat frequent premature ventricular complexes (PVCs) with LLTS. Methods and design: The present study will be a prospective multicenter, double-blind, randomized, controlled trial to assess the antiarrhythmic effects of LLTS on frequent PVCs in patients without structured heart disease (SHD). A total of 100 patients with PVC burden > 10% will be randomly assigned to the active or sham LLTS in 1:1 fashion and receive the proposed intervention for 6 months. The primary outcome is PVC burden at 6 months as assessed by 10 days of continuous ambulatory electrocardiographic monitoring. Secondary outcomes include heart rate variability (HRV), quality of life, skin sympathetic nerve activity, and inflammatory markers. Adverse events will also be recorded. Discussion: The present trial will be the first to evaluate the effect of LLTS on frequent PVCs on patients without SHD. LLTS may serve as a low-cost, minimal-risk, and non-invasive alternative to conventional antiarrhythmic therapy. Trial registration: ClinicalTrial.gov NCT04909528. Registered on 17 June 2021. World health organization trial registration data set was shown in Supplementary Table 1.
- 23 October 2023
- Published by Springer Nature in Trials
- Vol. 24 (1) , 1-10
Open AccessTranscutaneous electrical vagus nerve stimulation to suppress premature ventricular complexes (TREAT PVC): study protocol for a multi-center, double-blind, randomized controlled trial
Background: The autonomic nervous system can be responsible for the initiation and maintenance of arrhythmias. Low-level tragus stimulation (LLTS), a noninvasive form of autonomic neuromodulation, has been shown to be effective in treating atrial fibrillation. We intended to treat frequent premature ventricular complexes (PVCs) with LLTS. Methods and design: The present study will be a prospective multicenter, double-blind, randomized, controlled trial to assess the antiarrhythmic effects of LLTS on frequent PVCs in patients without structured heart disease (SHD). A total of 100 patients with PVC burden > 10% will be randomly assigned to the active or sham LLTS in 1:1 fashion and receive the proposed intervention for 6 months. The primary outcome is PVC burden at 6 months as assessed by 10 days of continuous ambulatory electrocardiographic monitoring. Secondary outcomes include heart rate variability (HRV), quality of life, skin sympathetic nerve activity, and inflammatory markers. Adverse events will also be recorded. Discussion: The present trial will be the first to evaluate the effect of LLTS on frequent PVCs on patients without SHD. LLTS may serve as a low-cost, minimal-risk, and non-invasive alternative to conventional antiarrhythmic therapy. Trial registration: ClinicalTrial.gov NCT04909528. Registered on 17 June 2021. World health organization trial registration data set was shown in Supplementary Table 1.